There has been a noticeable increase in interest among corporate and financial players in pursuing carve-outs and strategic acquisitions, driven by the need to adapt to shifting global challenges such as AI-driven technological disruption, climate change, and economic uncertainties. While corporations continue to focus on divesting non-core assets to align with their strategic transformations − including bolstering AI capabilities and sustainability goals − financial investors demonstrate a sustained appetite for acquiring carved-out assets, aiming to unlock future value through reorientation and buy-and-build strategies. This trend builds on the post-2022 recovery, with corporate buyers increasingly leveraging M&A for growth and resilience, as evidenced by PwC’s 28th Annual Global CEO Survey finding that 42% of CEOs believe their companies will no longer be viable in ten years without significant transformation.
Looking ahead into 2026, corporations and financial investors are prioritising a balance between expansion and financial resilience amid persistent valuation gaps and financing headwinds. Corporations are ramping up joint ventures, partnerships, and acquisitions of attractive Belgian targets (particularly in AI, life sciences and biotech) to drive international growth, while financial investors − often partnering with family offices − plan aggressive acquisition pipelines.
Traditional bank financing remains constrained by high interest rates and ESG scrutiny. As such, alternative funding, cost optimisation and strategic alliances are centre stage; 93% of corporate buyers and 90% of financial investors anticipate an increase in M&A activity in the coming year.
Despite geopolitical risks, trade tensions and economic volatility, the market is poised for further upturn − with 85% of European deal-makers planning M&A and 50% expecting volume growth, led by Benelux. As such, corporates and investors are well positioned to harness technology M&A for transformative efficiencies and a competitive edge in 2026.
ESG Considerations
Formerly considered a risk to be avoided, ESG is currently recognised as one of the most substantial opportunities for value creation and transformative industry shifts in the current era. This is particularly important given the upcoming enforcement of certain obligations under the EU’s Corporate Sustainability Reporting Directive (CSRD). Specifically, large public interest entities and companies currently subject to the EU’s Non-Financial Reporting Directive (NFRD) must demonstrate compliance with these requirements by 2025.
With sustainability considerations becoming more influential, Belgian companies are facing greater pressure to align their operations with these principles. This marks a clear shift towards integrating sustainability values into the core of business strategies and decision-making processes. Demonstrating a proactive stance in sustainability not only sets companies apart but also acts as a pivotal factor in fostering long-term goals such as establishing valuable supplier relationships, meeting rising customer expectations, and attracting acquirers seeking to bolster their ESG profiles.
Forging partnerships across the value chain is crucial, enabling resource combination, the scaling of progress, and the enhancement of data gathering and protocols in pursuit of sustainable initiatives. Such partnerships can be forged through strategic M&A transactions to further increase customer penetration and accelerate growth.
AI and Life Sciences
One of the key cornerstones for successfully deploying an AI ecosystem remains access to top-tier human capital in AI. Buyers increasingly target acqui-hires of early-stage enterprises (often with minimal or no revenue) purely to secure skilled talent. Belgium, renowned for its world-class human capital from institutions such as the Interuniversity Microelectronics Centre (IMEC) (see 5.1 Trends: Spin-Offs) and KU Leuven, continues to solidify its position as a pivotal global hub drawing intense international attention − not just for cutting-edge innovations but as a prime destination for technology and life sciences M&A. This dynamic environment, bolstered by more than 70% of venture capital inflows in the first half of 2024 being channelled into AI start-ups, fosters relentless growth, cross-sector collaboration, and abundant investment opportunities. As a result, Belgian targets are positioned at the forefront of strategic acquisitions.
A dominant trend in AI is its explosive integration into healthcare, revolutionising disease diagnosis, personalised medicine and AI-powered drug discovery, as exemplified by high-profile deals such as Recursion’s acquisition of Exscientia. Belgium’s unique life sciences ecosystem − thriving on fertile synergies between biotech, medtech, pharmaceuticals and healthcare − is underpinned by a robust financing landscape and proactive government support, including clusters such as BioVille and Ghent Bio-Energy Valley.
Post-2022 downturn, the sector has spectacularly rebounded: Belgian listed biotechs now boast a market cap of EUR66.8 billion (up 42.7% year-on-year), reaffirming Belgium as Europe’s leading biotech market − ahead of all peers − with flagships such as argenx and UCB driving resilience. European life sciences M&A surged to USD48.3 billion in the first half of 2025 alone (exceeding full-year 2024), with AI and demographic tailwinds set to propel even greater activity, cementing Belgium’s role in transformative deals.
New start-up companies are typically incorporated in Belgium as a private limited liability company (besloten vennootschap, or BV/société à responsabilité limitée, or SRL). Belgian corporate law provides a flexible corporate framework for the organisation of companies. There is no initial capital requirement for incorporation of a private limited liability company ‒ although it must have sufficient equity for the first three years to perform the envisaged activities, as shown in a financial plan that is filed with the notary at incorporation. See 2.2 Type of Entity for further details.
To establish a limited liability company in Belgium, the primary time-consuming tasks involve obtaining a bank account and crafting a financial plan. Once these prerequisites are fulfilled, the incorporation process necessitates the execution of a notarial deed before a Belgian notary, which typically takes approximately two weeks.
Entrepreneurs are commonly encouraged to opt for a private limited liability company (BV/SRL). This business structure is specifically crafted to offer flexibility, allowing entrepreneurs to customise incorporation documents according to their specific requirements. In contrast to the public limited liability company (naamloze vennootschap, or NV/société anonyme, or SA), there is no requirement of a minimum capital but – as mentioned in 2.1 Establishing a New Company – the assets must be sufficient in the light of the activity envisaged. A contribution of assets without the issuance of new shares in the private limited liability company can proceed simply via a decision by simple majority of the shareholders.
Nonetheless, any choice of business structure should be considered from a tax perspective. It is advisable to consult a legal and tax adviser for more detailed advice on which company structure is best suited to specific needs.
Early-stage financing, also known as seed investment, for start-ups can be sourced from various channels – each with its own unique characteristics. Here are some of the key providers and their respective documentation processes.
Each financing option has its specific requirements and documentation procedures. Entrepreneurs should carefully consider the terms and conditions of each source and engage legal and financial professionals to ensure clarity and compliance with financial regulations.
Venture capital funds secure their funding predominantly from family offices, private funds and individual angel investors. Although less common, additional investors in venture capital funds may include government-backed institutions and investment companies, such as Noshaq, Participatiemaatschappij Vlaanderen NV, Limburgse Reconversiemaatschappij NV, Federale Participatie-en Investeringsmaatschappij NV and Belgian Growth Fund Comm V.
Belgium does not have specific nationwide regulations or standards governing venture capital documentation. The structuring and documentation of venture capital deals must be in line with general contractual and corporate law and typically depends on negotiations between the parties involved – investors, start-ups and legal professionals.
Belgian corporate law offers a highly flexible framework for organising companies, eliminating the necessity for start-ups to undergo changes in their corporate structure as they progress in development. Notably, even a private limited liability company (BV/SRL) can be listed on a securities exchange, enhancing the versatility of Belgium’s corporate landscape.
Given Belgium’s appeal as a conducive home for companies across all developmental phases, the need to migrate to another jurisdiction is infrequent. Only if a start-up plans significant international expansion might it explore options that facilitate global operations, such as setting up subsidiaries in other jurisdictions.
Belgium primarily emphasises its support for SMEs, a sector that may not find significant advantages in IPOs. Consequently, Belgian companies often turn to private equity transactions or other funds as a means of securing funding and enhancing their financial standing. IPOs are notably infrequent as an exit strategy in Belgium.
Although the IPO is widely acknowledged as a prestigious and lucrative way to gather funds, secondary sales and trade sales are frequently favoured for achieving a complete exit by shareholders. In contrast to the IPO, where shareholders often retain their positions, secondary sales and trade sales tend to result in a complete exit for shareholders.
Dual-track processes are typically adopted by investors seeking optimal flexibility and fostering competitive tension between the M&A and IPO paths. Owing to the substantial internal resources required, dual-track processes are generally reserved for companies exceeding a certain minimum size threshold.
Euronext Brussels
Euronext is a pan-European exchange that combines the stock exchanges of Amsterdam, Brussels, Lisbon and Paris into a single market. Euronext also has representatives in Germany, Switzerland, Spain and Italy. From young, growth-oriented companies to long-established enterprises, Euronext offers various types of markets with multiple entry points to provide issuers with a tailor-made listing offer.
Euronext Brussels is cited as a centre of excellence in biotech and has distinguished itself in regulated real estate companies. If the company is active in these sectors, listing on Euronext Brussels may be strategic because of the knowledge and investor community present. If the company already operates in Belgium, it may be familiar with local regulations and Euronext Brussels listing requirements. This can ease the process of an IPO compared with exploring a foreign exchange.
Euronext has recently invested in new technologies to automate the trading of financial products and has indicated its desire to grow by attracting new companies to list their shares on the exchange. Although there are challenges, such as regulatory issues and growing competition from other exchanges, Euronext Brussels has a strong position as a major player in the Belgian economy and as part of the European stock exchange.
Primary Equity Markets on Euronext Brussels
Euronext Brussels classifies issuers into three compartments based on their market capitalisation:
Alternative Trading Platforms
Euronext Growth (formerly Alternext) is designed for mid-cap companies, offering a less stringent regulatory environment to avoid International Financing Reporting Standards publication requirements. It maintains rules for investor transparency and protection.
Euronext Access (formerly Free Market) is a non-regulated trading facility with significantly relaxed requirements for SMEs – for example, on free float and transparency.
Foreign Listings in Belgium
While listings of foreign companies in Belgium are limited, exceptions include notable companies such as argenx (BEL 20 index member), Shurgard Self-Storage, Brederode and Acacia Pharma. Some foreign companies also have secondary listings on Euronext Brussels, including Ahold Delhaize, Aperam (BEL 20 index constituent), ENGIE, Euronext, ING Groep, Saint-Gobain, Suez and Total. These foreign listings constitute less than 15% of the total listed companies.
The decision to list on a foreign exchange does not impede the possibility of a future sale. Belgian corporate law and financial law will still govern minority squeeze-out rules and other corporate restructuring measures, regardless of a foreign listing. Nevertheless, managing transactions across two or more jurisdictions does introduce additional complexities to the process of a future sale.
The sale of a company held by venture capital is often orchestrated as an auction, strategically harnessing competitive tension to its maximum potential. A positive correlation can be established between the use of competitive auctions and the transaction value. More than three out of four transactions with values exceeding EUR100 million are preceded by a competitive auction. In contrast, only one in three transactions with values between EUR10 million and EUR100 million involve such auctions, and competitive auctions occur in less than one in five transactions valued below EUR10 million.
In the present market landscape, initiating bilateral negotiations from the outset is the exception rather than the rule. It is important to note, however, that not every auction maintains its competitive intensity until the final phase. In numerous instances, only a handful of bidders remain actively engaged until the closing stages, and – occasionally – certain bidders successfully secure exclusivity.
The typical structure for the sale of a privately held technology company involves the sale of shares, as corporate capital gains on shares are 100% tax-exempt as long as the following conditions are met.
If any of the above-mentioned conditions are not fulfilled, corporate entities pay a 25% capital gains tax.
Consideration for asset transactions usually arises when there are significant tax advantages, if shareholders prefer to sell specific assets exclusively, or if the acquiring party has concerns about potential legacy liabilities within the company. Prospective bidders may propose that active founders continue their involvement in the company for a specified duration, often linked to the inclusion of a deferred consideration element, such as an earn-out.
Transactions primarily involve cash considerations – although there are instances where a minor portion of the consideration is settled in stock (ie, the company’s shareholders receive shares of the acquiring entity). Complete stock-for-stock transactions are rare.
Founders and venture capital investors are typically tasked with supporting representations, warranties and a comprehensive tax indemnity. This responsibility extends to specific indemnities concerning significant liabilities unearthed during due diligence, such as those related to pensions, litigation and environmental matters. Investors and venture capitalists, however, often seek to shift this responsibility onto the selling founders or management of the company.
The use of an escrow account is typical, being used in around 28% of all transactions. The warranty and indemnity (W&I) insurance mechanism bypasses the need to block part of the purchase price as a security for potential liability claims. Mainly owing to the involvement of larger and more sophisticated foreign investors and private equity funds, W&I insurance is present in more than one in four cases for Belgian transactions with a value of more than EUR100 million. In contrast, only a small percentage of transactions with a deal value up to EUR10 million adopt W&I insurance, as the cost thereof may be too high. Where sellers are in a strong position (eg, competitive auctions), the use of W&I insurance is more likely. W&I insurance may be used more frequently in tech M&A because private equity funds and financial investors do not want to assume long-lasting representations and warranties for IP, privacy and cyber-risks, and also may be used to preserve relations with the founder who sold their equity and the management that rolled over a portion of their equity.
Spin-offs thrive across various domains, including universities, research institutes and government entities. IMEC, an esteemed international research and development organisation headquartered in Belgium, specialises in nanoelectronics and digital technologies. With a rich history, IMEC has consistently fostered the emergence of innovative start-ups through spin-offs within these domains.
Corporate spin-offs are a strategic tool frequently employed by large corporations to divest non-core businesses. Although they may not be the predominant restructuring method, certain spin-offs have garnered substantial public attention. A notable example is the Euronext Brussels-listed chemical company Solvay, which announced plans to undergo a separation into two distinct independent public companies in December 2023. This strategic move involves establishing one entity for its traditional chemicals business and another dedicated to its high-technology materials and solutions.
In Belgium, spin-off transactions can be structured as tax-free transactions. For a movable pre-tax dividend in the form of shares of a new or existing company following the transfer of a business division, the following requirements must be met.
Although a spin-off followed by a business combination is technically permissible under Belgian law, it is important to note that such a sequence of transactions is not a standard practice in Belgium.
The execution of spin-offs necessitates meticulous preparation, encompassing operational, business, tax and legal considerations to ensure day-one readiness. As a result, the entire spin-off process typically extends over a minimum of one year. Although obtaining a ruling from the Belgian tax authorities is not mandatory before finalising a spin-off, such a ruling offers a level of assurance regarding the tax implications of a transaction that has not yet incurred fiscal consequences.
A strategic approach for a potential bidder involves:
Any transactions by the bidder or those acting in concert may be publicly disclosed before or at the start of the offer period, with general rules for significant shareholding disclosure applying throughout a public takeover bid.
If a potential bidder begins accumulating a stake, disclosure is mandatory once voting rights exceed specified thresholds, which are typically at 5% and multiples thereof (10%, 15%, etc) – although some listed companies may have lower thresholds (often 3%). Consideration must also be given to voting securities held by parties in concert, including affiliates and existing shareholders with specific arrangements. Upon announcing the public takeover bid, the bidder must disclose its existing voting securities in the target. Subsequent disclosures are required by the target, bidder, parties in concert and others involved, with daily updates during the takeover bid period submitted to the Belgian Financial Services and Markets Authority (FSMA) regarding the acquisition or disposal of relevant securities.
Under the authority of the FSMA, individuals who make statements – directly or through intermediaries – that raise questions about their intent for a public takeover bid can be compelled to make an announcement within a maximum period of ten business days (“put up or shut up”). Those confirming their intention must launch the bid within an agreed-upon timeframe with the FSMA. Failure to confirm within the set period bars both the individual and those acting in concert from initiating a takeover bid for the target company’s securities for six months following the announcement’s publication or the expiry of the FSMA-imposed declaration deadline, whichever is later.
Any acquisition, regardless of the quantity (even a single share), may be subject to prohibition or necessitate a mandatory bid for the target if it increases the shareholder’s aggregate holding to 30% or more. Nevertheless, the Belgian takeover rules outline specific circumstances where there is no obligation for a mandatory bid, even if a person passes the 30% threshold in outstanding voting securities. It is crucial to note that a mandatory bid, being a legal requirement, cannot be made conditional and is irrevocable once initiated. The procedural rules for a mandatory public takeover bid align with those for a voluntary bid, except in terms of conditionality and price considerations.
In Belgium, most transactions are share deals, mostly for tax reasons (in the absence of a capital gains tax, see 4.2 Liquidity Event: Transaction Structure). In 90% of all transactions, the purchase price is entirely paid in cash. Payment in shares or loan stock is very uncommon. On the other hand, a deferral of the payment of the purchase price is quite usual, being applied in 57% of all transactions. On average, around 22% of the purchase price is deferred for around 24 months. The use of an escrow account is also typical, being used in around 28% of all transactions.
In certain cases, a takeover may take the form of a corporate merger, wherein the merger becomes effective upon approval by the general shareholders’ meeting of the companies involved. This structure involves either merging both companies into a new entity or absorbing one company into the other. Opting for a corporate merger offers advantages over a takeover bid, allowing the merging companies to compel all shareholders to participate and become shareholders in the surviving entity.
However, drawbacks include the need for co-operation from the target company’s board and limitations on a cash portion of the merger consideration (capped at 10%). Corporate mergers are often preferred when the consideration comprises exclusively new shares in the surviving entity or when – post-takeover – the bidder aims to squeeze out minority shareholders of the target company by making them shareholders of the bidder, leveraging a previously acquired significant shareholding in the target company.
Consideration for a bid could be in cash, shares, other securities or a combination thereof. In voluntary bids offering shares or securities, the bidder must provide a cash alternative under certain conditions ‒ for example, where the bidder or a party acting with them acquired more than 1% of the target’s securities in cash within the preceding 12 months. There is also a requirement for the consideration to include liquid securities listed on a regulated market. For voluntary bids, there is no minimum consideration set by regulations, but the FSMA mandates that the bid terms allow for a reasonable success rate. Equal consideration for all shareholders is essential and, if shares outside the bid are acquired at a higher price, the bid price automatically increases. In a counterbid, the consideration must be at least 5% higher than the previous offer.
Mandatory bids must offer consideration at least equal to the higher of the highest price paid for the securities by the bidder in the 12 months preceding the bid’s announcement or the weighted average market price during the 30 days before the triggering event. The FSMA can impose additional conditions or adjustments if these rules are violated.
Controlling shareholders’ bids require consideration review by an independent expert appointed by the target’s independent directors. If no independent directors exist, the target’s governance body appoints the expert with FSMA approval. The expert evaluates whether the consideration is fair compared to a bid in a competitive market.
The Belgian Takeover Act mandates that a bid must encompass all securities issued by the target and possess terms ensuring its viability and irrevocability. Although bids can be contingent on competition or regulatory approvals, the FSMA can also approve other objective conditions, including acceptance thresholds, the absence of material adverse events beyond the bidder’s control, restrictions on dividends, and no amendments to the target’s articles of association. However, in practice, the FSMA tends to be cautious about imposing conditions that might hinder the bid’s success.
Agreements With Shareholders
In the context of recommended takeovers, it is customary for bidders to establish a memorandum of understanding (MoU) with key shareholders, and this practice is particularly pronounced given the prevalent ownership structure in many listed Belgian companies. Prior to publicly announcing the bid, bidders engage in negotiations to formalise these agreements. The MoU serves as a comprehensive document, specifying commitments from key shareholders, which typically include their agreement to accept the bid and commit to tendering their securities. Additionally, key shareholders agree not to transfer or dispose of their securities before the bid’s closure unless it is part of accepting the bid, and they pledge not to solicit or engage in discussions related to any third-party bid. Importantly, these specific undertakings are mandated to be disclosed in the prospectus – a crucial step that enhances transparency throughout the entire takeover process.
Agreements in Recommended Bids
In the event of a recommended bid, the bidder and the target – if endorsed by the target’s board – can mutually agree on various bid-related matters. These agreements, encompassing non-solicitation, exclusivity, break-up fees, treasury share tendering and standstill obligations, must be disclosed in the prospectus.
Although comfort letters and letters of intent are typically favoured over formal agreements, it is advised that the target’s board – even if favourably disposed towards the bidder – maintains a neutral stance to avoid discouraging potential counter-bidders who might present superior prospects or a better price for the target’s security holders. The neutrality of the target’s board is emphasised in letters of intent.
The target’s board – adhering to the general rule of acting in the target’s best interest – must objectively assess any counter-bid in the response memorandum. In doing so, it must consider the overall welfare of the target, its security holders, creditors and employees.
The Takeover Decree mandates that a bid encompasses all securities issued by the target and possesses terms ensuring its viability and irrevocability. Although bids can be contingent on competition authority or other regulatory approvals, the FSMA may approve additional objective conditions, such as an acceptance threshold, the absence of a material adverse event beyond the bidder’s control, the withholding of dividends, and no amendments to the target’s articles of association. However, it is noteworthy that the FSMA tends to hesitate when it comes to imposing conditions that could potentially impede the success of the bid in practice.
A holder possessing 95% of a company’s voting securities has the authority to compel all other holders of voting securities to tender their securities through a squeeze-out bid. This bid can be initiated independently by a person already holding 95% of voting securities or as part of a public takeover bid – voluntary or mandatory – where the bidder secures 95% of outstanding voting securities.
In the context of a public takeover bid, specific conditions must be met, including the bidder holding 95% of the share capital with voting rights and voting securities and acquiring at least 90% of the relevant share capital through the bid. If these conditions are met, the bid is reopened for at least 15 business days, commencing within three months after the initial acceptance period. Any untendered securities automatically transfer to the bidder.
In a standalone squeeze-out bid, an independent expert must assess the offered price, which can only be in cash. In the event of a summarised squeeze-out bid, non-accepting securities holders have the right to demand acquisition on the same terms.
Post-takeover bid, for one year, the bidder and those acting in concert are prohibited from acquiring applicable securities on more favourable terms without compensating all previous tendering security holders for the price difference.
Before initiating a public takeover bid, a bidder is required to formally notify the FSMA of their intention and secure the FSMA’s authorisation to proceed with the announcement. Simultaneously, the bidder must complete the essential paperwork for the actual commencement of the public takeover bid. Once the public takeover bid is announced, withdrawal is typically not permitted, except in specific circumstances. This entails submitting pertinent documents, such as a draft prospectus and evidence of fund certainty if the offer involves cash. The latter can take the form of an unconditional and irrevocable bank credit facility or funds held in a bank account with a credit institution licensed in Belgium. For exchange offers, the bidder must demonstrate to the FSMA the availability of securities for the exchange, either through ownership, immediate access, or the ability to procure these securities within the stipulated timeframe (potentially from an affiliated entity).
In the context of friendly takeover bids, potential bidders typically strive to secure the support of the target company through tactics such as exclusivity commitments and break-fee agreements. However, in the Belgian market, the prevalence of break fees is limited – given the difficulty in convincing the target’s board to compensate the initial bidder for incurred costs in the event of a bid failure.
Although there are no strict legal prohibitions on such commitments, their value and enforceability may be restricted owing to the overarching obligation of a Belgian company’s board to act in the corporate interest, ensuring equal treatment of all shareholders. Notably, potential bidders can derive reassurance from the fact that the authority of the target company’s board is restricted during a takeover bid, reducing the potential for obstructive actions.
If a bidder cannot obtain 100% ownership over a target company but possesses 95% of the share capital of the target (and 90% in case of a voluntary takeover), they can resort to squeeze-out mechanisms (see 6.8 Squeeze-Out Mechanisms).
If a bidder does not seek to acquire 100% ownership over a target company or fails to obtain the necessary share capital to resort to squeeze-out mechanisms, contractual agreements to strengthen governance rights are possible. This may involve engaging with other reference shareholders to secure specific privileges in a shareholders’ agreement, such as the ability to nominate individuals for director positions within the target company. Given the distinctive context of listed companies, obtaining robust protective rights such as veto powers or control over reserved matters could prove to be a formidable challenge, if not an outright impossibility. However, it must be noted that a partial tender offer (seeking less than 100%) is not permitted in a public takeover bid, except in the case of a self-tender by a company to acquire its own shares.
In addition to break fees, no-shop clauses and the authorised capital principle, Belgian M&A transactions frequently incorporate non-competition and non-solicitation clauses extending for a period of two to three years following the transaction’s closure. Given that a substantial number of Belgian listed companies are under the control of one or more shareholders, irrevocable commitments are commonly employed in Belgium. It is important to note, however, that shareholders retain the ability to withdraw such commitments at any point in time.
In Belgium, before initiating a takeover bid, the bidder must inform the FSMA, which reviews compliance with takeover rules. Once publicly announced, the bid cannot be withdrawn, except in specific circumstances. The FSMA provides the target company’s board with the bidder’s prospectus – a process taking four to six weeks or, where there are antitrust or market controversies, potentially longer. The target’s board has five days to flag issues in the draft.
After FSMA approval of the prospectus, the target’s board submits a response memorandum within five days, subject to FSMA review. In friendly bids, this may coincide with prospectus review. The acceptance period begins five business days after the FSMA approves the prospectus or immediately after response memorandum approval (if earlier). Counter-bids and higher bids must be FSMA-announced at least two days before the last bid’s acceptance period expires. This framework ensures transparency and regulatory oversight in Belgian takeover processes.
The takeover process spans approximately ten to 12 weeks, commencing with the preparatory stage ahead of the first approach and concluding with the settlement – subject to regulatory approvals and specific timelines for each step.
Regulatory approvals, including competition clearance, play a crucial role in the takeover process. In Belgium, these approvals are sought after the public bid announcement. The competition clearance process involves a simplified or standard procedure, with timelines ranging from 15 to 60 business days, depending on the complexity. Serious concerns may trigger an in-depth investigation (Phase II). Notably, transactions cannot be closed until merger clearance is granted, which makes regulatory approval a prerequisite for the completion of the bid.
The ability to extend the takeover offer period hinges on regulatory approvals – notably, competition clearance. If approvals are not obtained before the offer period expires, parties may consider an extension. The terms for extension align with the regulatory framework. The process involves a simplified or standard procedure, with the Belgian Competition Authority aiming to approve the transaction within specified timelines. Until competition clearance is secured, transactions cannot be finalised, making bids conditional on obtaining regulatory approval.
Beyond adhering to general commercial and corporate law and overarching regulations such as the GDPR, technology companies may need specialised permits and approvals, particularly in highly regulated sectors such as financial services, gambling and telecommunications.
Financial Services
Financial services generally require a licence if offered in Belgium (either directly or on a cross-border basis). These licences depend on the type of service offered – for example, banking services, investment services, payment services, electronic money issuance and credit services. Whether the provision and marketing of financial services to Belgian clients trigger the applicability of Belgian law should be analysed on a case-by-case basis.
Gambling
Obtaining a licence is mandatory for all forms of gambling, whether online or land-based. The licensing framework is structured, with a limited number of licences per category. Online licences are exclusively available to providers already holding a land-based licence. These procedures are very specific and can be time-consuming.
Telecommunications
Subject to a few exceptions, telecommunications providers in Belgium are required to notify the Belgian Institute for Postal Services and Telecommunications about the commencement of their activities in Belgium.
The FSMA is the principal securities regulator for public M&A transactions in Belgium.
The Belgian foreign direct investment (FDI) screening mechanism became effective on 1 July 2023. The FDI screening mechanism distinguishes between three types of foreign investors:
Every type of investment by a foreign investor aimed at establishing or maintaining lasting direct relationships with the target company in a certain sector, including through the effective participation in the management or control of the company (eg, through ownership of shares or by acquiring voting rights), is envisaged by the FDI screening mechanism. Although this definition seems very broad, the only foreign investments that will fall within the scope of the FDI screening mechanism are foreign investments that are by foreign investors seeking to gain control of − or, depending on the sector of the target company, acquire 10% or 25% of the voting rights in − a Belgium company, in which the foreign investment will either:
The FDI screening mechanism has several phases, as follows.
Each ISC member drafts a final opinion (positive or negative), potentially including mitigating measures. Negotiations occur, leading to a binding agreement. Competent ministers and college members make preliminary decisions based on ISC opinions. These decisions are conveyed to the ISC Secretariat, which combines them into a final decision: approval, approval with mitigating measures, or refusal if the impact is non-remediable and at least one competent authority provides negative advice. Certain actions suspend time periods, and complex investments can extend the ISC advisory period to two months.
Besides the screening of foreign investments listed in 7.3 Restrictions on Foreign Investments, Belgium enforces EU regulations on export controls, applicable at both federal and regional levels (including the Flemish, Walloon and Brussels-Capital Regions). The country is part of international regimes such as the Wassenaar Arrangement, the Nuclear Suppliers Group, the Australia Group, the Missile Technology Control Regime, and the Zangger Committee.
Dual-use goods, military items and cultural goods are subject to export controls. The regulatory framework involves various laws, such as the EU Dual-Use Regulation, and regional decrees. The application process for export licences varies by region and denial decisions can be appealed administratively. Violations incur civil or criminal penalties, including fines, imprisonment and licence revocation. Mitigation is possible under certain conditions.
Belgium lacks a specific procedure for voluntary self-disclosure but considers it when determining penalties. Specific restrictions on exports to countries such as China, Israel, Turkey, Pakistan, Saudi Arabia and the UAE are maintained – each subject to particular conditions and considerations. Authorities do not publish public lists of denied entities, but some regions have specific policies regarding certain export restrictions.
The relevant legislation governing merger control in Belgium is found in Book IV of the Code of Economic Law, the Royal Decree of 30 August 2013 on the notification of concentrations, and the EU Merger Regulation. The scope of legislation covers mergers where independent undertakings merge, acquire control over another undertaking or form full-function joint ventures. The definition of “control” is broad, including the acquisition of minority shareholdings.
The jurisdictional thresholds for notification require an aggregate Belgian turnover exceeding EUR100 million and individual turnovers of at least EUR40 million for at least two of the parties. The Belgian Competition Authority may investigate non-notifiable mergers if they potentially constitute an abuse of a dominant position. Book IV of the Code of Economic Law does not apply to concentrations falling under the EU Merger Regulation, except for specified cases. Mandatory filing is required for concentrations that surpass the turnover thresholds. Notification of concentrations must be submitted to the Competition Prosecutor General before the transaction is finalised, with no exceptions to this rule.
Acquirers should primarily be cautious about the following topics in an M&A transaction.
Approval or Information/Consultation Requirements
In an asset sale
In the event of an asset deal, whether through a transfer ut singuli or a transfer under a Belgian Code on Companies and Associations procedure, meeting the criteria for a transfer of undertaking – as defined by Collective Bargaining Agreement (CBA) No 32bis – triggers the obligation to inform and engage employees.
In a share sale
The duty to inform and consult employees, among other responsibilities, materialises when a share transfer results in a concentration or implies a significant structural change under negotiation by the company. Concentration is recognised when a transfer of shares confers control upon the buyer over a formerly autonomous company, triggering the obligation for both the acquiring entity (buyer) and the target company (subject to control acquisition) to inform and consult.
Parties to be informed
The determination of who should be informed and/or consulted hinges on the presence of employee representation bodies within the company in question. At the national level, the key employee representation bodies include the Works Council (Ondernemingsraad/Conseil d’entreprise), the trade union delegation (syndicale afvaardiging/délégation syndicale) and the Committee for Prevention and Protection at Work (Comité voor Preventie en Bescherming op het Werk/Comité pour la Prévention et la Protection au Travail). In the absence of a Works Council, social dialogue occurs at the level of the trade union delegation.
If neither of these bodies exists within the company, the Committee for Prevention and Protection at Work becomes the designated employee representation body that must be informed and consulted regarding the transaction. If, however, there are no employee representation bodies at the company (or companies) in question, the obligation to inform and consult individual employees about the (contemplated) transaction does not apply unless the transaction qualifies as a transfer of undertaking within the meaning of CBA No 32bis.
Timing and procedure in an asset and share sale
Employees have the right to be informed, obliging employers to share transaction details for employees to understand the company’s socio-economic context. Timing-wise, employee representative bodies should receive information before any public announcement of a concrete proposal for a transaction decision – typically just before finalising the acquisition agreement. Regardless, the information provision and consultation process must be concluded before the final decision on the transaction.
Consultation aims to foster dialogue between employee representatives and the employer concerning the transaction, sparking debate on whether this duty applies only to employment-impacting transactions.
For transfers under CBA No 32bis, in the absence of representative bodies, individual employees must be informed about the transfer’s date, rationale, legal and economic implications, and proposed measures. In cross-border transactions, the European Works Council must be informed and consulted as required.
Protection Against Dismissal
If CBA 32bis applies, employees cannot be dismissed owing to the transfer, whether initiated by the buyer or the seller. Violating this prohibition may lead terminated employees to seek damages, in addition to severance indemnity (ranging from three to 17 weeks’ salary). These considerations underscore the importance of a comprehensive understanding of local legal intricacies for acquirers engaging in M&A transactions.
Prohibited Practices
Two prohibited practices that can regularly be found during the due diligence of a technology company are set out here.
Sham self-employment
Engaging in sham self-employment in Belgium, where individuals assume the status of self-employed while working under an employer’s authority, can lead to significant consequences. Authorities may re-qualify such individuals as employees, demanding both employer and employee contributions – potentially increased with interest and surcharges. Clients/employers cannot recover these contributions. The re-qualified employee may also claim retroactive payment for salary elements, such as end-of-year premiums and holiday pay. The deemed employer is obliged to pay double holiday pay and end-of-year premiums within a five-year statute of limitations. Additionally, other aspects of Belgian employment law – including termination regulations – apply. The Social Security Authorities have a three-year period (up to seven years in cases of fraud) to make claims, whereas employees have five years to assert their claims.
Posting of workers
The posting of workers in Belgium involves a situation where a worker – typically employed in countries other than Belgium – is loaned to a Belgian user by their employer, who exercises authority over the worker. The employment relationship between the foreign undertaking and the posted worker should exist prior to posting and be maintained during the posting period. Employers posting workers to Belgium must adhere to Belgian working conditions, including pay, as mandated by legal and regulatory provisions and sanctioned under criminal law. These provisions cover various aspects, including working time, remuneration, leave, worker welfare and non-discrimination. Violations can result in legal consequences. These issues should in general be covered in the representations and warranties, whereas concrete risks established during the due diligence should be covered by specific indemnities. They may also require post-closing actions.
IP Considerations
The copyright for a creative work is initially vested in the individual who created it. Consequently, the employee-creator retains ownership of the copyrights for works developed within the scope of their employment contract. However, there is provision for the partial transfer of these rights, limited to the property rights of the copyright-protected works, which can be transferred to the employer. It is crucial that any such transfer, whether full or partial, is explicitly outlined in the employment contract or a separate agreement between the employer and employee. Simply remunerating the employee-creator is insufficient for acquiring these rights; the creation of the work must also fall within the parameters of the employment contract.
Furthermore, Belgium does not have a “work for hire” regime, which implies that if someone is commissioned to create a work for a company (such as a logo or website design), the individual author(s) will automatically hold the copyright to that work. Consequently, proper due diligence should be performed on IP clauses in work rules, employment contracts or other agreements such as consultancy agreements.
In contrast, although the law around IP rights in software, databases and semiconductor topographies (chips) is based on copyright, the issue of software creations in an employment context is regulated completely differently. The basic principle here is that the employer is presumed to acquire the property rights to software, databases and topographies unless the employer and the employee have agreed otherwise. Thus, in these particular contexts, there is a legal presumption of transfer of IP economic rights to the employer. It is up to the employee to provide evidence that the presumption does not apply – for example, because the work was not created under the employment contract.
Currency Control
The European Central Bank regulates the euro and keeps inflation under control.
Central Bank Approval
No central bank approval is necessary unless specific cases of M&A arise within the insurance and credit sectors.
Besides the screening of foreign investments listed in 7.3 Restrictions on Foreign Investments, there are multiple legal developments affecting the Belgium M&A landscape.
New Belgian B2B Rules
The Belgian Act of 4 April 2019 entered into force on 1 December 2020, and its effects are still not yet fully known. It introduced a set of rules on prohibited B2B contract clauses that apply to all B2B agreements, except those for financial services. It therefore includes M&A contractual arrangements.
The rules include a general fairness principle, a black list of clauses that are deemed always abusive, and a grey list of clauses deemed abusive unless proven to the contrary. A clause may be deemed abusive if it creates on its own, or together with other clauses, a clear imbalance between the rights and obligations of the parties that is of a legal and not an economic nature. The core clauses of agreements, such as those on price, fall outside the scope of this balance test. If a clause is deemed abusive, it will be declared null and void.
This relatively new set of rules must be taken into account when drafting M&A agreements. As there is only limited jurisprudence on them so far, it is currently uncertain how strictly these provisions will be interpreted by courts.
New Belgian Civil Code
The New Belgian Civil Code with an updated Belgian contract law entered into force on 1 January 2023, thereby impacting M&A agreements. Existing templates must be reviewed with regard to their relevance, whether or not certain clauses may remain in force, and whether others can be changed thanks to new options under the new law.
Cybersecurity
The Belgian Network and Information Systems Act of 26 April 2024 (the “NIS2 Act”), which transposes the EU’s Network and Information Security (NIS) 2 Directive (the “NIS2 Directive”), came into force on 18 October 2024. Given that its text includes fines similar to those found in the EU’s General Data Protection Regulation (GDPR), it may be a first step towards forcing essential and important organisations to focus more on cybersecurity.
However, the most important innovation is the extension of its scope. The NIS2 Act mandates 12 additional sectors to implement cybersecurity risk management measures and follow incident notification obligations. It enhances and streamlines security and reporting requirements by establishing a minimum list of key elements all entities must consider, including incident management, supply chain security, and vulnerability handling and disclosure. This means that it not only applies to “critical sectors” but also to other important sectors, such as digital services and digital infrastructure (telecommunications, data centres, cloud services, etc).
This means that it will also become more important to review a target’s compliance with the NIS2 Act, whenever applicable, during a due diligence. Cybersecurity may be the next hot topic in M&A after privacy became much more relevant in transactions.
New Digital EU Regulation
The impact of the Digital Services Act and the Digital Markets Act will have to be assessed during the due diligence on targets subject to these new regulations.
Attention should be paid to the EU’s Regulation 2024/1689 of 13 June 2024 laying down harmonised rules on artificial intelligence (the “EU AI Act”). Adopted on 13 June 2024, the EU AI Act entered into force on 1 August 2024, with a phased implementation schedule. The regulation focuses on specific AI applications in particular contexts and categories based on risk to health, safety and fundamental rights. The impact of the EU AI Act will have to be assessed during the due diligence on targets subject to the new regulation. IP and privacy compliance will vary based on the risk level posed by AI, determining the specific obligations for providers and users alike.
Foreign Direct Investment Screening
Belgium’s Interfederal Screening Commission (ISC) – operational since July 2023 – has for the first time imposed remedial measures in three high-profile acquisitions involving non-EU investors (from Canada, China, and the United States) targeting critical sectors including space, software development/services and semiconductors. To avert risks to vital process continuity, sensitive data/know-how leakage, and strategic dependencies, the ISC mandated safeguards such as third-party escrow of technology/source code, operational continuity guarantees and compliance officer appointments – likely encompassing the early 2025 acquisition of Flemish IT powerhouse Cipal Schaubroeck (serving 276 local governments) by Canada's Constellation Software via its Dutch arm. Amid 217 notifications to date (with 197 unconditional approvals, zero prohibitions, and deal values surging to EUR7 billion in the latest year), sensitive information, digital infrastructure, and energy dominate, primarily from US/UK/Japan/Canada/China investors in Flanders – signalling a pro-investment yet security-first stance that tech M&A practitioners must navigate in 2026 via early ISC engagement and proactive mitigation.
Machine learning, deep learning, neural networks and other forms of artificial intelligence are often already an integral part of a target’s business operations when conducting technology M&A. When conducting the due diligence and drafting M&A documentation in relation to an artificial intelligence (AI) company, buyers should give special attention to IP protection of data sets and algorithms (eg, copyright, trade secrets and patents), ownership of intellectual property developed by AI, ownership of content generated by AI, licensing issues, liability issues, regulatory, privacy and cybersecurity. Privacy is also, of course, essential (eg, transparency obligations).
EU AI Act
Attention should be paid to the European Union’s Regulation 2024/1689 of 13 June 2024 laying down harmonised rules on artificial intelligence, commonly known as the EU AI Act. This regulation aims to harmonise rules on artificial intelligence, emphasising ethics and EU values to foster the responsible development and use of AI technology. The application of the AI Act began in February 2025, with the first provisions becoming mandatory for businesses. Additional key regulations will follow in the months ahead, and the entire law will be applicable from 1 August 2026, except for certain high-risk AI systems. The timeline is as follows:
Compliance with the AI Act varies based on the risk level posed by AI systems, determining specific obligations for providers and users. The Act categories AI systems into four risk levels.
Internet of Things and Autonomous Driving
Internet of things (IoT) devices often contain components of different manufacturers. They are often low-price devices with low levels of security. So, when acquiring manufacturers or operators of IoT devices buyers should properly review liability, intellectual property, privacy, IT security and consumer protection (such as the new digital sales rules) issues. However, the IoT could also raise additional environmental (eg, waste management) or health and safety issues.
Key technologies relating to autonomous or semi-autonomous driving include, among others, automated automotive technologies, collision avoidance technologies, artificial intelligence and machine learning. When acquiring companies in this field, sellers should focus on the ownership of these technologies (eg, patents, trade secrets), ownership of data, regulatory issues (eg, government authorisations, test results) and insurance.
Data
If a target is involved with big data, the seller should, during its due diligence, prioritise the following areas of the target’s business operations related to information and its related risks and liabilities:
FDI
The Belgian FDI screening mechanism became effective as of 1 July 2023. During the due diligence, whether the transaction at hand would fall under the scope of the FDI regime (see 7.3 Restrictions on Foreign Investments) should be assessed.
Public M&A
In the context of a recommended bid, it is advisable – albeit not mandatory – to undertake due diligence before initiating a public takeover bid, particularly to validate the bid price. This process includes releasing an information memorandum on the target, conducting management presentations, and reviewing specific documents accessible through a data room.
The target board has the authority to decide when and what information about the target will be disclosed, taking into account factors such as the corporate interest of the target, confidentiality obligations, equal treatment of shareholders, and considerations related to insider dealing and competition. If the target board is hesitant to disclose sensitive information, it can opt for vendor or third-party due diligence, ensuring that the same information is provided to any competing bidder per the Takeover Decree.
Bidders are cautioned against obtaining insider dealing information and, if acquired, it must be disclosed in the prospectus. In the case of a hostile bid, the bidder typically relies on publicly available information in order to decide whether to proceed with the bid.
Private M&A
Due diligence in technology M&A transactions – particularly with regard to IP assets, privacy and cybersecurity concerns – is crucial for acquiring technology companies. Emphasis is placed on analysing owned and third-party IP, IP disputes and IT assets.
The review includes a focus on IP ownership under Belgian copyright law, recognising that software protection is limited to the form and expression of ideas. The due diligence extends beyond ownership to assess transferability, addressing key questions about the technology’s origin, development, inventors, available IP rights and compliance with obligations.
The nature of legal due diligence varies based on whether the transaction involves asset or share purchase, with special attention paid to IP and data asset transferability in technology M&A. The impact of the EU AI Act will have to be assessed during the due diligence on targets subject to the new EU AI Act. IP and privacy compliance will vary based on the risk level posed by AI, determining the specific obligations for providers and users alike.
Data Protection Considerations During M&A Process
The due diligence process for technology companies typically involves the transfer of personal data from the seller to the buyer. As a result, these data-processing activities must adhere to general data protection requirements. Specifically, compliance with the GDPR necessitates a legal basis. By way of example, the release of relevant data can be justified on the grounds of legitimate interests, such as facilitating the M&A transaction. However, certain information may need to be anonymised, including employee names and sensitive personal data such as health information.
Additional complexities arise when the potential buyer is located outside the EU, as international transfers of personal data require specific privacy safeguards. If the seller has engaged a data room provider to oversee the data room, it is crucial to provide clear instructions in the data-processing agreement regarding handling a potential data breach. Furthermore, it is advisable to maintain the data room within the EEA to minimise the transfer of EU personal data to non-European Economic Area (EEA) countries. If the seller is managing the data room internally or through a law firm, although a data processing agreement may not be required, it is essential to implement suitable technical and organisational safeguards. Moreover, implementing EU Standard Contractual Clauses or alternative transfer tools with potential buyers should be contemplated if there is a potential need to transfer data to a non-EEA country at a later stage in the transaction.
If data needs to be transferred to the USA, the EU–US Data Privacy Framework (DPF) could be relied upon, as this was approved by the EC on 10 July 2023. By doing so, the EC confirmed that personal data transferred to the USA under the DPF is adequately protected in line with the rules on international data transfers imposed by the GDPR.
Data Protection Considerations During Due Diligence of Target
In order to avoid acquiring non-compliant businesses, buyers must conduct a comprehensive evaluation of the target’s data protection compliance. Identified non-compliance can be addressed before closing; or factored into risk assessments, valuations, or indemnification mechanisms. Conducting a post-closing data protection audit is suggested so as to remediate potential breaches quickly. The due diligence process should involve requesting various documents from the seller to assess the target’s data protection compliance status, covering processing activities, relevant documents, IT and security measures, expert assessments, data breach documentation, impact assessments, IT program compliance, cybersecurity policies, legal proceedings, disputes and insurance coverage.
Non-compliance with data protection laws in a target’s data-processing activities poses significant risks for buyers, as violations of the GDPR can result in fines of up to EUR20 million or 4% of the total worldwide annual turnover. Recent high-profile data breaches underscore the risks associated with data security, exposing companies to liabilities from shareholder lawsuits, government investigations, remediation costs and reputational damage. Juniper Research predicts that the global cost of data breaches will reach USD5 trillion by 2024. National data protection authorities – including the Belgian Data Protection Authority – have imposed substantial fines, emphasising the GDPR’s importance.
Buyers must also consider the impact of new regulations such as the EU AI Act, which introduces transparency, risk management and accountability requirements that extend to data governance practices for AI systems. This regulation, effective as of 1 August 2024 with phased implementation, underscores the importance of responsible data management practices that align with EU data ethics and security standards. Fines for not complying with the EU AI Act could go up to 7% of global annual turnover for violations of banned AI applications, up to 3% for violations of other obligations, and up to 1.5% for supplying incorrect information.
In accordance with Belgian public takeover bid regulations, only the FSMA is authorised to declare a public takeover bid and – prior to the FSMA’s public announcement – no party (including the bidder or the target company) is allowed to disclose the initiation of such a bid. This restriction applies even if the target company is obliged to announce the bid launch under the general disclosure obligations.
A bidder intending to declare a public takeover bid must first notify the FSMA of its intention and secure the FSMA’s approval before making the official announcement. Simultaneously, the bidder must complete the requisite filings for the actual initiation of a public takeover bid, which includes providing evidence of funding certainty in the case of a cash offer and submitting a draft prospectus. Once a public takeover bid is announced, withdrawal is typically not permitted, except in specific circumstances.
In the event of rumours or leaks concerning a potential bidder’s intentions to launch a public takeover bid, the FSMA has the authority to compel the party concerned to disclose its intentions (early disclosure of the announcement if required for the good functioning of the markets or “put up or shut up” as described in 6.1 Stakebuilding). Special rules govern self-tenders by the issuer of securities.
The bidder is required to meticulously prepare a prospectus for the takeover bid, detailing the bid’s terms and conditions and incorporating essential information tailored to the characteristics of the bidder, target company and relevant securities. This includes clear presentation for ease of analysis and comprehension.
The Belgian public takeover bid rules specify a minimum information checklist for inclusion in the prospectus, which must undergo approval by the FSMA before publication. Any new significant facts, substantial errors or inaccuracies emerging or discovered between FSMA approval and the expiry of the bid’s acceptance period must be promptly addressed in a prospectus supplement, which is subject to FSMA approval and dissemination in the same manner as the original prospectus.
The prospectus itself is required to be prepared in both Dutch and French, unless the bidder demonstrates that the target company customarily publishes financial information in a specific language – in which case, the FSMA may accept a prospectus in that language. The summary of the prospectus must be drawn up in both Dutch and French. In cases where takeover bid communications are disseminated in only one Belgian official language, the summary may be limited to that language.
The prospectus for a public takeover bid in Belgium must encompass the bid’s terms, conditions and all necessary information for the public to conduct a comprehensive assessment. Financial details about the bidder and the target, the bid’s characteristics, the bidder’s objectives and the target board’s response memorandum are also essential components.
The draft prospectus must be filed with the FSMA. Initial verification will be conducted with the FSMA, where informal comments will be sought. Subsequently, a definitive version must be submitted to the FSMA for approval and subsequent publication.
The responsibilities of directors in Belgium, as outlined by both Belgian law and possibly the company’s articles of association, encompass the overall management of the company, formulation of its strategic direction, and representation in dealings with external parties. Directors are obliged to exercise reasonable care and diligence – all while upholding confidentiality and prioritising the company’s interests. Specific obligations arise in the context of M&A transactions, especially within corporate restructuring procedures outlined in Chapter 12 of the Belgian Code on Companies and Associations.
For publicly traded companies, the Public Takeover Act imposes additional duties on the governing body of the target. This includes a preliminary declaration to verify the draft prospectus for omissions or misleading information and a subsequent memorandum in response to the approved prospectus. This memorandum addresses various aspects such as comments on the prospectus, statutory clauses affecting securities transferability, opinions on the offer’s consequences, the bidder’s strategic plans, and the opportunity for security holders to sell their securities.
The company must treat shareholders and certificate holders who are in similar circumstances in the same way. The articles of association may provide that shares of a particular class or designation have special controlling rights in the company under the articles of association. Notably, Belgian law does not prescribe specific duties for controlling shareholders in M&A transactions.
Belgian law does not require the formation of a special committee in respect of a takeover offer.
In general, the initiation of a takeover bid does not necessitate approval from the target’s board. However, the target’s board has the option to provide input on the bid through commenting on the completeness and potentially misleading aspects of the draft prospectus and formulating a response memorandum that may incorporate dissenting views. Nevertheless, practical considerations often lead the response memorandum to align with the opinions of the (controlling) shareholders, owing to their substantial representation on the board.
Additionally, a defensive tactic employed by the target’s board against (hostile) takeovers involves leveraging the concept of “authorised capital”, granting the board discretionary power to increase the target’s capital as deemed necessary. Directors can take defensive measures as long as these are in the company’s best interest. In this context, the target board must – in particular – take into account the interests of all security holders, as well as those of its employees and creditors.
In the context of a business combination, companies typically enlist the support of investment banks and legal professionals – occasionally seeking guidance from consultants and other experts to provide insights on the proposed transaction. As a standard part of due diligence, the board of directors and supervisory directors often obtain fairness opinions from financial advisers in order to evaluate the appropriateness of the transaction price. Although seeking advice does not absolve directors of their responsibilities, it can be considered a mitigating factor when evaluating their actions in a legal context later on.
Sinter-Goedeleplein 14
1000 Brussels
Belgium
+32 476 60 91 82
sds@allegiance.law www.allegiance.law
The Rise of AI as a Strategic Driver in Tech M&A
Technology has become central to M&A strategy as executive teams return to the deal table with a sharper focus on durable technology moats, including proprietary data, secure and scalable infrastructure, and deployable AI capabilities that accelerate growth or margin. Generative AI and broader general purpose AI systems are transforming operating models and creating new integration challenges. Companies now emphasise AI not only in the investment thesis but across the entire deal lifecycle, from target screening and diligence to post closing value creation. This article will reflect on these trends and also provide an overview of the Belgian tech M&A environment and practical Belgian law considerations for AI infused transactions.
For clarity, “GenAI systems” refers to models designed to produce novel outputs such as text, images, code, audio or other data by learning patterns from training data, as distinct from systems focused primarily on classification or prediction. In practice, buyers increasingly encounter hybrid stacks that combine GenAI with retrieval augmented generation, predictive models and traditional analytics.
In this landscape, technology due diligence – covering IT, cybersecurity, data governance and digital strategy – has become essential. It tests alignment between technology strategy and growth ambitions, shows the capital and operating expenditure required to sustain competitiveness, and reveals hidden security or operational risks. AI specific assessments are rising in importance, probing data set provenance, model governance, compliance with emerging regulation and concrete value creation use cases. Robust technology diligence enables better pricing, tighter risk allocation, and smoother integrations or carve outs.
The adoption of GenAI during M&A transactions has risen from a small base over 2024–25. Even where adoption remains below one third of deal teams, early users report speed and coverage gains in document review, red flagging, analytics and bid preparation. Across the transaction lifecycle, GenAI can accelerate data analysis and synthesis, streamline diligence by extracting, clustering and summarising large volumes of contracts and policies, and enhance valuation work by rapidly generating scenario models and sensitivities.
GenAI adds value from the strategy and deal identification stage, where continuous screening models ingest public filings, news, hiring signals and product telemetry to identify targets aligned with a strategic thesis, and where an analyst co-pilot can generate and refresh research memos, market maps and competitive landscapes with sources logged for verification by the deal team. During deal preparation and execution, GenAI supports buy-side diligence through contract abstraction on change of control, assignment, data localisation, audit and IP clauses; policy gap analysis on GDPR, NIS2 and AI Act readiness; and code and licence scans for open-source compliance. On the sell-side, it assists with data room quality assurance, consistent Q&A responses, generation of disclosure schedules and clean team extracts that respect antitrust protocols. For valuation support, it enables rapid scenario modelling and KPI correlation analysis to evidence the monetisation path, including attach rates, lifetime value uplift and cost-to-serve reduction.
Post deal integration and management also benefit from GenAI through the drafting and harmonisation of security baselines, data retention rules, model governance frameworks and acceptable use policies, as well as through skills mapping and learning pathways. The use of AI in recruitment should be approached carefully given the likely classification of such tools as high-risk under the EU AI Act. In the transformation and value realisation phase, GenAI can power a “use case factory” by scoring pipelines for impact versus feasibility, enabling pilots with appropriate guardrails and tracking benefits tied to synergy cases, while also supporting risk sensing through continuous monitoring for model drift, bias, privacy leakage and shadow AI.
Legal, Regulatory and Due Diligence Considerations for AI-Infused Transactions
Using GenAI in deals and acquiring AI-rich businesses raises distinct legal and regulatory issues that Belgian buyers and sellers should prioritise. From a data protection and confidentiality perspective, parties should avoid inputting confidential deal information or personal data into public models and should prefer on-premises, virtual private cloud or vendor private instances with contractual prohibitions against training on client data and enforceable audit rights. Legal privilege should be maintained by defining approved tools in engagement letters and internal protocols, and by channelling privileged analyses through counsel-controlled environments. For international transfers in cross-border data rooms, valid transfer mechanisms such as the EU-U.S. Data Privacy Framework or standard contractual clauses with transfer impact assessments should be ensured, and log retention should be limited.
EU AI Act readiness is now a core consideration. The Act entered into force in 2024 with phased application through 2025–27, with prohibited practices applying first and transparency duties for general purpose and GenAI models and high-risk obligations following on a staggered basis. See 9.1 Due Diligence Process in the Belgian Law & Practice chapter in this guide for further detail of the EU AI Act's implementation. Parties should expect governance, risk management, data quality, technical documentation, post-market monitoring and incident reporting requirements. Diligence should therefore request an AI system inventory and classification, conformity assessment status for high risk use cases, model and system cards, data governance evidence including provenance, copyright compliance and bias testing, measures for human oversight, and alignment with harmonised standards or applicable codes of practice.
Cybersecurity and NIS2 obligations also require attention. NIS2 expands the scope and depth of security and incident reporting duties for essential and important entities and their supply chains. Diligence should assess maturity against frameworks such as ISO 27001 and NIST, ransomware resilience, third-party risk and regulatory notification history, and should contract for uplift plans where gaps are material. The EU Data Act, applying from late 2025, strengthens data sharing frameworks and cloud switching, so diligence should test data access rights, portability, egress fees, lock-in risk and compliance roadmaps for connected products and services. Competition and antitrust risks must be managed through strict clean team protocols, particularly for model weights, proprietary data sets and pricing algorithms, and parties should avoid exchanging competitively sensitive information outside approved structures, especially given the increased risk of referrals under Article 22 of the EU Merger Regulation and a focus on data and AI capabilities even below traditional thresholds.
Regulatory process checkpoints (where progress might be halted) affecting Belgian tech deals have become more pronounced. The Belgian foreign direct investment screening regime is now firmly embedded, with sensitive targets in AI, semiconductors, biotech, critical infrastructure and large data sets routinely requiring notification. Standstill obligations apply, pre-notification and Q&A can be extensive, and parties should build buffers into long stop dates. The Foreign Subsidies Regulation notification regime is fully operational, so transactions involving non-EU financial contributions should be screened early, with information requests that can be burdensome and may run in parallel with merger control. EU merger control itself reflects closer scrutiny of data consolidation and ecosystem effects, including an increased use of Article 22 referrals; internal documents on AI strategy and monetisation are frequently requested.
Intellectual property and open-source questions are equally significant. Copyright in the EU requires human authorship, meaning ownership claims over purely machine-generated outputs may be weak. Buyers should validate training data licensing, check for text and data mining opt-outs, secure vendor indemnities, and confirm appropriate geofencing of data sets. Open-source software scans should be run to surface copyleft or restrictive licences and to remediate issues. Belgian employment and social dialogue considerations arise where monitoring or productivity AI tools are deployed, as these may trigger information and consultation duties with the works council or employee representatives and must comply with Belgian privacy and labour law principles such as proportionality and transparency, with data protection impact assessments where needed. Trade secrets should be protected in and beyond the data room by marking and tracking exports, restricting model access to synthetic or minimised data, and maintaining audit trails for prompts and outputs used in decision-making.
A comprehensive technology and AI diligence playbook for both buyers and sellers should cover architecture and security, including cloud topology, identity and access controls, encryption, secure software development lifecycles, penetration and red team results, incident logs and lessons learned. It should address data assets through inventories, lineage, quality metrics, lawful bases, consents, data retention and localisation practices, sharing agreements and readiness for the Data Act. It should scrutinise AI and machine learning governance by reviewing the model registry, evaluation protocols, bias and robustness testing, drift monitoring, rollback and kill switches, and third-party model and vendor risk. It should assess the IP position across copyright and database rights, the patent pipeline, trade secret controls, the open-source bill of materials, third-party claims and indemnities. It should map regulatory status under the GDPR, NIS2 and the AI Act, including certifications, data protection impact assessments, conformity assessments, supervisory interactions and remediation plans. It should test commercial traction through evidence of AI use case return on investment, attach rates, churn impact, pricing strategy and customer references, as well as dependency on a single model or vendor. Finally, it should review the roadmap and investment plan, including capital and operating expenditure for compliance and scaling, talent gaps, and the feasibility of on-premises or sovereign deployments for sensitive sectors.
Drafting trends and risk allocation in Belgian share purchase agreements increasingly incorporate AI-specific representations and warranties that cover compliance with applicable AI, privacy and cybersecurity law, accuracy of system classification, completeness of technical documentation, data set provenance and lawful use, absence of undisclosed third-party rights, open-source compliance and the disclosure of incidents. Covenants and interim operating restrictions often include a standstill on releasing high risk AI features pre-closing without buyer consent, limits on migrating to new foundation model vendors, and requirements to maintain security baselines and logging. Conditions precedent and deliverables may require regulatory clearances under foreign direct investment rules, the Foreign Subsidies Regulation and merger control, and, where material, delivery of AI Act conformity documentation or third-party certifications alongside remediation plans for identified gaps. Indemnities and caps are increasingly tailored, with targeted protections for legacy data or IP infringement and security incidents tied to AI systems, longer survival periods for privacy, cyber and AI breaches, and sub-limits where remediation is feasible. Warranty and indemnity insurance policies are also evolving, with more exclusions around data provenance, cyber-hygiene and AI compliance unless buyers perform enhanced diligence and negotiate specific endorsements.
The Belgian Tech M&A Landscape and the Road Ahead
Post-closing integration should be structured to secure the value creation thesis by:
Parties should also prepare for upcoming regulatory milestones under the AI Act, the Data Act and NIS2 with a funded, time-bound plan.
The Belgian tech M&A landscape in 2024–25 has been characterised by stabilising rates and pent-up private equity capital supporting a pick-up in processes, with renewed appetite for corporate carve-outs and growth deals. Process discipline has improved as buyers demand clearer routes to AI monetisation and defensible data moats. Software remains the primary magnet for capital, with strong interest in AI infrastructure, data tooling, cybersecurity and vertical SaaS, while hardware tied to AI – such as edge compute, sensors and specialised devices – has seen selective momentum. International investors remain highly active alongside a robust domestic venture capital ecosystem, and employee stock ownership plans are increasingly standard to attract and retain talent amid acute competition for senior AI engineers. Although IPOs remain muted, trade sales and secondary buyouts continue, with incremental growth in structured exits and earn-outs linked to AI milestones or revenue quality.
Looking ahead to 2025–26, regulation will continue to shape diligence scopes, deal timetables and integration budgets. Early identification of AI Act classifications and Data Act exposures will help avoid surprises on price and risk allocation. Buyers are likely to pay a premium for clean data rights, demonstrable AI return on investment and secure engineering, while opaque data provenance, weak governance or vendor lock-in will depress valuations or invite specific indemnities. Broader use of private or sovereign AI deployments is expected in sensitive sectors such as health, finance and the public sphere, together with more alliances with EU-located model providers. In Belgium, continued foreign participation, steady mid-market activity and strong demand for AI-augmented assets are anticipated, with execution success hinging on the depth of technology diligence and proactive regulatory navigation.
Sinter-Goedeleplein 14
1000 Brussels
Belgium
+32 476 60 91 82
sds@allegiance.law allegiance.law